These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 11098334

  • 1. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
    Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M.
    Ann Pharmacother; 2000 Nov; 34(11):1238-42. PubMed ID: 11098334
    [Abstract] [Full Text] [Related]

  • 2. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.
    Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH.
    Thorax; 1997 Nov; 52(11):987-93. PubMed ID: 9487348
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M, Nazareth D, Walshaw M.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
    [Abstract] [Full Text] [Related]

  • 7. Outpatient intravenous medications in the management of cystic fibrosis.
    Rucker RW, Harrison GM.
    Pediatrics; 1974 Sep; 54(3):358-60. PubMed ID: 4213282
    [No Abstract] [Full Text] [Related]

  • 8. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N, Markantonis SL, Dimitrakis E, Panidis D, Boutzouka E, Karatzas S, Rafailidis P, Apostolakos H, Baltopoulos G.
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [Abstract] [Full Text] [Related]

  • 9. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
    Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA.
    Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.
    Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG.
    Pediatr Pulmonol; 2013 Jan; 48(1):1-7. PubMed ID: 22949160
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL, Parada JP, Belmares J, O'Keefe JP.
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.